Targeting the K-Ras/PDEδ protein-protein interaction: the solution for Ras-driven cancers or just another therapeutic mirage? [electronic resource]
- ChemMedChem Oct 2013
- 1620-2 p. digital
Publication Type: Journal Article
1860-7187
10.1002/cmdc.201300311 doi
Animals Antineoplastic Agents--pharmacology Cyclic Nucleotide Phosphodiesterases, Type 6--antagonists & inhibitors Drug Design Drug Resistance, Neoplasm Humans Neoplasms--drug therapy Protein Interaction Domains and Motifs--drug effects Proto-Oncogene Proteins--antagonists & inhibitors Proto-Oncogene Proteins p21(ras) ras Proteins--antagonists & inhibitors